Search

everythinglearnresearchcommunity

for

Search:↓

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

People with alopecia areata often have lower vitamin D levels than healthy people.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

There is no significant link between metabolic syndrome and alopecia areata.

Siddha medicine can effectively treat Alopecia areata, leading to significant hair regrowth.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

The summit aimed to speed up finding treatments for alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.